A recent study suggests that the shingles vaccine may offer additional health benefits beyond its primary purpose of preventing herpes zoster.Researchers found potential links between vaccination and reduced dementia risk, slower aging, fewer strokes, and lower mortality rates.However, conclusive evidence requires further randomized controlled trials.

The article highlights concerns about South Africa's low adult vaccination uptake, with experts noting that the flu vaccine offers similar health benefits but is more accessible.

While the shingles vaccine (Shingrix) demonstrates promise in mitigating age-related conditions, its high cost and limited public sector rollout remain barriers.

Public health discussions focus on balancing clinical evidence, affordability, and healthcare system capacity to address potential widespread adoption of the vaccine.